Fate Therapeutics
World Rank (Jan-05-2024)
14,336
Market Cap (Jan-05-2024)
0.379 Billion USD
World Rank (Jul-30-2023)
13,932
Market Cap (Jul-30-2023)
0.414 Billion USD
World Rank (Dec-25-2022)
8,052
Market Cap (Dec-25-2022)
1.070 Billion USD
World Rank (Jan-07-2022)
3,499
Market Cap (Jan-07-2022)
4.61 Billion USD
Annual Revenue in USD
55 Million USD
Annual Net Income in USD
-212 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Fate Therapeutics is a Clinical Stage Biopharmaceutical company. The company is dedicated to the development of next generation cellular immunotherapies for cancer and immune disorders. The headquarters is in USA.
Company Website